Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,710 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High incidence of post transplant lymphoproliferative disorder after antithymocyte globulin-based conditioning and ineffective prediction by day 28 EBV-specific T lymphocyte counts.
Hoegh-Petersen M, Goodyear D, Geddes MN, Liu S, Ugarte-Torres A, Liu Y, Walker JT, Fonseca K, Daly A, Duggan P, Stewart D, Russell JA, Storek J. Hoegh-Petersen M, et al. Among authors: stewart d. Bone Marrow Transplant. 2011 Aug;46(8):1104-12. doi: 10.1038/bmt.2010.272. Epub 2010 Nov 8. Bone Marrow Transplant. 2011. PMID: 21057556
Fludarabine, busulfan, antithymocyte globulin, and total body irradiation for pretransplantation conditioning in acute lymphoblastic leukemia: excellent outcomes in all but older patients with comorbidities.
Daly A, Savoie ML, Geddes M, Chaudhry A, Stewart D, Duggan P, Bahlis N, Storek J, Brown C, Shafey M, Turner AR, Russell J. Daly A, et al. Among authors: stewart d. Biol Blood Marrow Transplant. 2012 Dec;18(12):1921-6. doi: 10.1016/j.bbmt.2012.07.017. Epub 2012 Jul 27. Biol Blood Marrow Transplant. 2012. PMID: 22842330 Free article.
Transplantation from matched siblings using once-daily intravenous busulfan/fludarabine with thymoglobulin: a myeloablative regimen with low nonrelapse mortality in all but older patients with high-risk disease.
Russell JA, Duan Q, Chaudhry MA, Savoie ML, Balogh A, Turner AR, Larratt L, Storek J, Bahlis NJ, Brown CB, Quinlan D, Geddes M, Zacarias N, Daly A, Duggan P, Stewart DA. Russell JA, et al. Among authors: stewart da. Biol Blood Marrow Transplant. 2008 Aug;14(8):888-95. doi: 10.1016/j.bbmt.2008.05.010. Biol Blood Marrow Transplant. 2008. PMID: 18640572 Free article. Clinical Trial.
The addition of 400 cGY total body irradiation to a regimen incorporating once-daily intravenous busulfan, fludarabine, and antithymocyte globulin reduces relapse without affecting nonrelapse mortality in acute myelogenous leukemia.
Russell JA, Irish W, Balogh A, Chaudhry MA, Savoie ML, Turner AR, Larratt L, Storek J, Bahlis NJ, Brown CB, Quinlan D, Geddes M, Zacarias N, Daly A, Duggan P, Stewart DA. Russell JA, et al. Among authors: stewart da. Biol Blood Marrow Transplant. 2010 Apr;16(4):509-14. doi: 10.1016/j.bbmt.2009.11.017. Epub 2009 Dec 3. Biol Blood Marrow Transplant. 2010. PMID: 19948235 Free article.
Immune reconstitution after anti-thymocyte globulin-conditioned hematopoietic cell transplantation.
Bosch M, Dhadda M, Hoegh-Petersen M, Liu Y, Hagel LM, Podgorny P, Ugarte-Torres A, Khan FM, Luider J, Auer-Grzesiak I, Mansoor A, Russell JA, Daly A, Stewart DA, Maloney D, Boeckh M, Storek J. Bosch M, et al. Among authors: stewart da. Cytotherapy. 2012 Nov;14(10):1258-75. doi: 10.3109/14653249.2012.715243. Epub 2012 Sep 18. Cytotherapy. 2012. PMID: 22985195 Free PMC article. Clinical Trial.
Establishing a target exposure for once-daily intravenous busulfan given with fludarabine and thymoglobulin before allogeneic transplantation.
Russell JA, Kangarloo SB, Williamson T, Chaudhry MA, Savoie ML, Turner AR, Larratt L, Storek J, Bahlis NJ, Shafey M, Brown CB, Yang M, Geddes M, Zacarias N, Yue P, Duggan P, Stewart DA, Daly A. Russell JA, et al. Biol Blood Marrow Transplant. 2013 Sep;19(9):1381-6. doi: 10.1016/j.bbmt.2013.07.002. Epub 2013 Jul 17. Biol Blood Marrow Transplant. 2013. PMID: 23871781 Free article.
Immune cell subset counts associated with graft-versus-host disease.
Podgorny PJ, Liu Y, Dharmani-Khan P, Pratt LM, Jamani K, Luider J, Auer-Grzesiak I, Mansoor A, Williamson TS, Ugarte-Torres A, Hoegh-Petersen M, Stewart DA, Daly A, Khan FM, Russell JA, Storek J. Podgorny PJ, et al. Biol Blood Marrow Transplant. 2014 Apr;20(4):450-62. doi: 10.1016/j.bbmt.2014.01.002. Epub 2014 Jan 6. Biol Blood Marrow Transplant. 2014. PMID: 24406506 Free article.
High serum level of antithymocyte globulin immediately before graft infusion is associated with a low likelihood of chronic, but not acute, graft-versus-host disease.
Chawla S, Dharmani-Khan P, Liu Y, Prokopishyn N, Amlish Munir M, Griffiths C, Khan FM, Stewart DA, Russell JA, Daly A, Storek J. Chawla S, et al. Biol Blood Marrow Transplant. 2014 Aug;20(8):1156-62. doi: 10.1016/j.bbmt.2014.04.007. Epub 2014 Apr 13. Biol Blood Marrow Transplant. 2014. PMID: 24727330 Free article.
Low Counts of B Cells, Natural Killer Cells, Monocytes, Dendritic Cells, Basophils, and Eosinophils are Associated with Postengraftment Infections after Allogeneic Hematopoietic Cell Transplantation.
Podgorny PJ, Pratt LM, Liu Y, Dharmani-Khan P, Luider J, Auer-Grzesiak I, Mansoor A, Williamson TS, Ugarte-Torres A, Hoegh-Petersen M, Khan FM, Larratt L, Jimenez-Zepeda VH, Stewart DA, Russell JA, Daly A, Storek J. Podgorny PJ, et al. Biol Blood Marrow Transplant. 2016 Jan;22(1):37-46. doi: 10.1016/j.bbmt.2015.09.003. Epub 2015 Sep 9. Biol Blood Marrow Transplant. 2016. PMID: 26363444 Free article.
4,710 results